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The  response  to  infection  with  Listeria  monocytogenes  is  characterized  by 
substantial host cell division involving lymphoid cells in the spleen and mature 
resident macrophages in the liver and peritoneal cavity (1, 2). Peak division of 
these cells is followed immediately by the expression  of high levels of antimi- 
crobial immunity; but the macrophages responsible for expressing anti-Listeria 
immunity in infective foci in the liver  are derived predominantly from circu- 
lating macrophage precursors which are being constantly produced by division 
(3). It would seem logical to postulate,  therefore, that the development of cell- 
mediated immunity to this infection should be highly vulnerable to the action 
of an antimitotic drug. 
In this  study,  the  Vinca alkaloid  vinblastine  (Vb)  was used  to  selectively 
destroy dividing host cells during infection. This compound irreversibly blocks 
cell division  at metaphase  (4).  It is particularly useful for this  type of study 
because it has  a  relatively short half-life in vivo (5),  and  therefore,  it can be 
used to destroy dividing cells over limited periods during the host response. 
It will be  shown  that  a  15  hr  pulse  of Vb  can inhibit  the  development  of 
cellular  immunity to a  primary Listeria infection,  provided it is administered 
to the host before infective loci become populated by activated macrophages. 
Materials and Methods 
The method for studying the growth of L. monocytogenes in the livers and spleens of mice 
was the same as that used in the preceding paper  (3). Infections were initiated  by the intra- 
venous injection of approximately 2 X  103 viable organisms. 
Vinblastine  sulfate  (Velban; Eli Lilly & Co., Indianapolis,  Ind.) was dissolved in 0.9% 
sodium chloride solution and administered intravenously. This drug has a half-life in mice of 
3.5 4- 1.2 hr (5). Therefore, a 100 ~g dose should ensure the destruction  of dividing host cells 
for about 15 hr. It was shown in preliminary experiments that Vb has no effect on the in vitro 
multiplication  of L. monocytogenes. 
Radiometry and radioautography  were performed in the same way as described previously 
(3). All histological observations were made on plastic-embedded liver. 
* This  investigation  was  supported  by Grant AI-07015 from  the National Institute  of 
Allergy and Infectious Diseases, United States Public Health Service. 
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RESULTS 
Effect of a 15 hr Pulse of Vinblastine  Given at Different  Times before and during 
Infection 
Pulsing before Infection.--A  large number  of mice were divided into groups 
according to whether  they received a  single  100/~g  injection of Vb  either  12, 
rt T-T2 
,~rT O 
24 
T-48 
CONT. 
I  t'  o  ~  ~  ~  4 
DAYS 
Fie. 1.  Effect of pulsing with Vb before infection.  Mice received a single 100  /~g dose of 
Vb either 48, 24, or 12 hr before infection  or at the time of infection.  Mice given Vb 12 hr 
before or at the time of infection failed to acquire immunity. Note that the effect of the drug 
was not apparent until between 48 and 72 hr of infection. 
24, or 48 hr before infection or at the time of infection. The effect of Vb, given 
at these times, on the growth curve of L. monocytogenes in the spleen is shown 
in Fig. 1, where it can be seen that the drug had no effect on the development 
of  host  resistance  when  given  48  hr  before  infection  and  had  only  a  partial 
effect when  given 24  hr later. In contrast, Vb given either 12  hr before, or at 
the time of infection, resulted in a  complete failure on the part of the host to 
acquire antimicrobial immunity. 
It  will be  noted  that  the  growth  curve  of L.  monocytogenes in  Vb-treated 
mice was almost identical with that in control mice up to the 2nd day of infec- R.  J.  ~OgT~  537 
tion.  The sudden  increase  in bacterial  growth in Vb-treated  mice between 48 
and 72 hr was more obvious in the liver,  as will be shown later. 
Pulsing  with  Vinblastine during  lnfection.--These  experiments  were  per- 
formed as above except that the Vb injections were given at the time of infec- 
tion or at 12,  24, 48, 72, or 96 hr during infection. Fig. 2 shows that the devel- 
opment of antimicrobial immunity could be completely or partially suppressed 
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FIG. 2.  Effect of pulsing with  Vb during infection. Mice injected at  12 or 24 hr during 
infection failed to acquire cellular resistance. Vb had no effect when given at 72 hr of infection 
or later  (results of pulsing at 96 or 120 hr are not included). Note that effect of drug did not 
become apparent  until 48-72 hr of infection. 
only during the first 48-72 hr of infection. After this time Vb had no significant 
effect on the host-parasite relationship. It is evident,  therefore, that Vb has no 
effect  on  established  immunity.  Instead,  it  interferes  with  host  components 
which  generate  this  immunity.  These  components were most sensitive  to Vb 
during the first 24 hr of infection. A  pulse of Vb given at  12 or 24 hr resulted 
in complete failure  to acquire control over bacterial multiplication,  whereas  a 
pulse given at 48 hr resulted in only a  temporary loss of immunity, indicating 
that the generation of antimicrobial immunity is partly completed by this time. 
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with  Vb  at  12  or 24 hr of infection was  almost identical with  that  in  control 
mice during the first 48 hr of infection. 
Effect of Vinblastine on Immunity in the Liver 
The foregoing results illustrated the effect of Vb on immunity in the spleen. 
It was found  in  all cases that  Vb  caused  the same effect on  immunity in  the 
liver. This  is partly illustrated in  Fig. 3  which  shows  the growth  curve  of L. 
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FIG. 3.  Growth curves of L. monocytogenes in livers of mice treated with Vb either before, 
at the time of, or early during infection. The liver curves serve to show the sudden  increase 
in bacterial multiplication between 48-72 hr of infection. 
monocytogenes in  the  livers of mice pulsed with  Vb  either just  before or just 
after initiating infection. It will be noted that the results are the same as those 
obtained for  the  spleen,  except that  the liver served  better  to  show  that  the 
growth curve of L. monocylogenes was the same in control mice and Vb-treated 
mice during the first 48 hr of infection. 
E~ect of Vb on the Division of Kup~er Cells during Infection 
It has been  suggested  (2)  that  the massive division of Kupffer cells during 
the 2nd  and 3rd days of a Listeria infection could be an important element in 
the development of resistance in this organ. The following experiment was per- R.  J.  NORTH  539 
formed in order to determine whether a suppression of Kupffer-cell division is 
responsible for the failure of mice to develop resistance when Vb is given at the 
time of infection. 
Mice were infected with L. monocytogenes and pulsed 30 rain later with 100 
#g of Vb. The division of Kupffer ceils was detected by flash labeling with 20 
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Fro. 4.  Effect of Vb on division of Kupffer cells during infection. Mice were pulsed with 
Vb 30 rain after initiating infection. Division of Kupffer cells was detected by flash labeling 
with TdR-3H at 24-hr intervals and counting liver DNA-3H by radiometry. An early pulse 
of Vb did not inhibit the division of liver macrophage. 
/zCi  of tritiated  thymidine,  as  described  previously  (2).  Fig.  4  shows  that  a 
pulse of Vb given at the time of infection did not suppress the subsequent in- 
corporation of TdR3H into Kupffer cells which began dividing  2  days later. 
In fact, it was found consistently that more incorporation occurs in Vb-treated 
mice. It is apparent,  then,  that cell division and the resulting increase in the 
number  of Kupffer cells  are  not  enough  in  themselves for  the  expression of 
antimicrobial immunity in  the  liver.  It is  evident  that  some additional  host 
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The Failure of Monocyte-Derived Macrophages to Populate Infective  Foci in the 
Livers of Vb-Treated Mice 
It has been shown previously (3) that acquisition of host immunity against 
infection with L. monocytogenes is coincident with the accumulation of mono- 
cyte-derived macrophages in infective foci in  the liver. It was  thought prob- 
able, therefore, that the suppression of immunity by Vb is due to its ability to 
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FIG. 5.  Effect of Vb on the influx of migrant macrophages into infected liver. Precursors of 
migrant macrophages were labeled with TdR-ZH 2 hr before infection, and  the mice were 
injected 30 rain later with Vb. After a further 30 rain, they were infected with L. monocyto- 
genes. Radiometry showed that labeled cells accumulated in infected livers of control mice 
during infection. No influx of labeled cells occurred in the livers of Vb-treated mice. 
destroy the precursors of monocytes which are known to be constantly dividing 
in bone marrow (6,  7).  Mice were injected intravenously with a single 20/zCi 
dose of TdR-3H and then injected again 30 nfin later with 100 #g of Vb. After 
a further 30 min, they were infected with a standard dose of L. monocylogenes. 
FIC. 6.  Infective foci in the livers of (a) control mice and (b)  Vb-treated mice on the 3rd 
day of infection. The infective foci in control mice are populated by macrophages, some of 
which were labeled by a pulse of TdR-~H 2 hr before infection. In contrast, the infective loci 
in Vb-treated mice are acellular,  and the parasite is growing unchallenged both extracellu- 
lafly and in surrounding parenchyma. X  560. 54i 542  SUPPRESSION  OF  CELL-MEDIATED  IMMUNITY  TO  INFECTION 
The livers of randomly selected mice were processed for radiometry and radio- 
autography immediately after initiating infection and on the 2nd and 3rd days 
of  infection.  Control  mice did  not  receive Vb.  Fig.  5  shows  that  a  pulse  of 
TdR-~H given to control mice 2 hr prior to infection resulted in  a  significant 
increase in liver DNA-*H during infection.  This increase did not occur in  the 
livers of mice which received Vb just before infection. Radioautography showed 
that  the  increase  in  liver DNA-DH in  control mice corresponded  to increased 
numbers  of labeled  macrophages in  sinusoids  and  in  infective foci  (Fig.  6a). 
They were derived from labeled precursors circulating in blood (3). In striking 
contrast  to  this,  no labeled macrophages were found  in  the livers of  the Vb- 
treated  mice. In fact,  the  infective loci  in  Vb-treated  mice failed  to  acquire 
macrophages (Fig. 6b), so that after 48 and 72 hr the lesions were acellular and 
contained large numbers of extracellular bacteria which  tended  to invade pa- 
renchymal cells and leak into sinusoids. 
Cytological Observations on Tissues of Infected Mice Treated with Vb 
The  aim of this  part of  the  study was to find  cytological evidence for  the 
antimitotic effect of Vb on those host cells which  are known to proliferate in 
response to infection. Mice were injected with 100 #g of Vb at different stages 
of infection. 4  hr  after the injection of Vb,  the livers and spleens of the mice 
were fixed in neutral formalin and  embedded in glycol methacrylate (3).  The 
spleens of all Vb- treated mice contained large numbers of mitotically arrested 
cells. The numbers were much higher, however, in the spleens of mice treated 
with Vb at 24 or 48 hr of infection (Fig.  7a). It was not until 48 hr,  however, 
that substantial mitotic activity developed in sinus-lining macrophages of the 
liver  (Fig.  7b).  In both organs,  mitotic figures were abnormal. It is obvious, 
therefore,  that  a  100  #g  dose of Vb  destroys large numbers  of dividing  host 
cells during infection. 
DISCUSSION 
This study shows that a  15 hr pulse of Vb given 12 hr before infection or up 
to about 24 hr during infection causes complete failure on the part of the host 
to generate effective antimicrobial immunity to a Listeria infection.  The drug 
has only a partial effect when given 24 hr before infection or 48 hr after initiat- 
ing infection;  and it is entirely without effect when given after 72 hr of infec- 
tion, i.e.,  when antimicrobial immunity is already established. The drug, there- 
fore,  does  not  interfere  with  the  functioning  of  the  activated  macrophages 
which are already engaged in destroying bacteria within infective loci. Its effect 
FIG. 7  Sections of liver and spleen of mouse which received Vb at 48 hr of infection. Ar- 
rested mitotic figures were allowed to accumulate in the liver and spleen for 4 hr before sacri- 
ficing the animal. Many mitotic figures in the spleen (a) are abnormal, and in some cases 
chromosomes have amalgamated into single clumps (arrows). The liver (b) contains Kupffer 
cells in mitotic arrest with abnormal chromosomes (arrows). X  2200. 543 544  SUPPRESSION  OF  CELL-MEDIATED  IMMUNITY  TO  INFECTION 
must  therefore result,  directly or indirectly, from its capacity to prevent the 
generation of these cells. 
It has been shown (3) that the onset of immunity to L. monocytogenes is co- 
incident with the accumulation of recently formed migrant macrophages in in- 
fective foci in  the liver.  These macrophages  are derived mainly from newly 
formed precursor cells  in  blood,  and it is  almost certain that  they are blood 
monocytes. Furthermore,  because  blood monocytes are  the  progeny of con- 
stantly dividing precursor cells in bone marrow (6,  7),  their formation should 
be highly vulnerable to the action of an antimitotic drug. A recent publication 
has shown (8) that a similar dose of Vb causes a dramatic fall in the number 
of circulating macrophage precursors in mice, and that it takes several days for 
their number to return to normal. This accords with the present finding that 
monocytes which should have been labeled by thymidine (given 2 hr before 
infection) failed to reach the lesions of animals which were also given Vb  at 
the time of infection. It seems that Vb must have blocked their production in 
bone marrow. 
According to the above interpretations, a pulse of Vb given as late as 48 hr 
of infection would not be expected to greatly interfere with the acquisition of 
immunity, because by this time infective foci already will have acquired some 
macrophages and will  continue to acquire those newly generated monocytes 
entering the blood. The observed partial suppression of immunity due to an 
injection of Vb at 48 hr of infection probably resulted from the destruction of 
a proportion of macrophages dividing in infective foci (2). It seems unlikely, 
from this and from a previous study (3), that the effect is due to destruction 
of dividing Kupffer cells. Presumably, the host response is no longer vulnerable 
to the action of Vb after 72 hr of infection because by this time enough mac- 
rophages will have accumulated in infective loci to insure continued bacterial 
elimination. 
Although the results of these experiments can be explained in terms of the 
direct action of Vb on the generation of host macrophage precursors, neverthe- 
less, why infective foci normally are not populated by macrophages until after 
48 hr of infection still needs to be explained. One reason for this may be that 
macrophages do in fact enter infective foci before this time, but most of them 
are destroyed because they have not, at this stage of the host response, acquired 
adequate antimicrobial mechanisms. In other words,  the macrophages which 
persist in infective foci are activated macrophages. There is evidence that the 
activation of host macrophages begins at 48 hr of a primary Listeria  infection 
(2)  and  that  this  occurs at a  time when specific delayed hypersensitivity to 
Lisleria  antigens is first detected (2). This evidence, together with that which 
shows that macrophage activation is immediately preceded by intense lymphoid 
cell proliferation in the spleen (1)  and that innnunity to L. monocytogenes can 
be  adoptively transferred to normal mice with lymphoid cells  from immune 
mice  (9), has led  to the  suggestion  that  macrophage  activation is  mediated 1~.  I.  NORTH  545 
through specifically sensitized lymphoid ceils. It is possible, therefore, that be- 
sides blocking the generation of circulating monocytes, Vb may have the addi- 
tional effect of interfering with another component of the host response by de- 
stroying proliferating lymphoid cells. If committed lymphocytes are necessary 
for the activation of host macrophages, their absence would have the same ul- 
timate  effect on resistance  as  would  the  blocking of macrophage production 
itself. This possibility can be studied in Vb-treated mice which have been re- 
constituted with lymphoid cells,  bone marrow cells,  or both. 
SUMMARY 
The development of acquired ceil-mediated immunity to infection with Lis- 
teria  monocytogenes  can be blocked by a  15 hr pulse of the  antimitotic drug, 
vinblastine (Vb). The drug has no effect on the host-parasite relationship after 
72 hr of infection when a high level of immunity is being expressed, i.e., when 
infective loci are populated by activated macrophages. Infective foci in mice 
treated  early during  infection with Vb do not  acquire migrant macrophages, 
but they become aceilular after 48 hr of infection. The results indicate that Vb 
destroys the dividing precursors of migrant macrophages. The possibility that 
Vb prevents the activation of these cells by destroying dividing lymphoid cells 
engaged in the specific immunological phase of the host response is  also con- 
sidered. 
I wish to thank Mr. Ion Deissler and Mrs. Sandra Lee Warner for expert technical assist- 
ance. 
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